Drug intelligence / Profile preview

AQT-004

Development stage
Preclinical
Lead developer
Aquavit Pharmaceuticals
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Intradermal
01

Overview

**AQT-004**, also known as **MICROTOX**, is an Aquavit Pharmaceuticals drug-device combination product designed for intradermal microchannel delivery of botulinum toxin in aesthetic and dermatologic applications. The proprietary delivery system is intended to distribute botulinum toxin superficially across skin tissue through microchannels, supporting pan-facial microinjection rather than conventional deeper intramuscular neurotoxin injection. The exact botulinum toxin active ingredient, dose, and final marketed formulation have not been publicly specified for AQT-004.

Other names
MICROTOX
02

Targets

SNAP25 (Synaptosome-associated protein 25)

Beyond the preview

Go deeper on AQT-004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AQT-004.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call